These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30714464)

  • 21. A Pilot Study of the Effect of Deployment on the Gut Microbiome and Traveler's Diarrhea Susceptibility.
    Stamps BW; Lyon WJ; Irvin AP; Kelley-Loughnane N; Goodson MS
    Front Cell Infect Microbiol; 2020; 10():589297. PubMed ID: 33384968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intestinal microbiome disruption in patients in a long-term acute care hospital: A case for development of microbiome disruption indices to improve infection prevention.
    Halpin AL; de Man TJ; Kraft CS; Perry KA; Chan AW; Lieu S; Mikell J; Limbago BM; McDonald LC
    Am J Infect Control; 2016 Jul; 44(7):830-6. PubMed ID: 26905790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinctive Gut Microbiota Is Associated with Diarrheagenic
    Gallardo P; Izquierdo M; Vidal RM; Chamorro-Veloso N; Rosselló-Móra R; O'Ryan M; Farfán MJ
    Front Cell Infect Microbiol; 2017; 7():424. PubMed ID: 29075617
    [No Abstract]   [Full Text] [Related]  

  • 24. Gut microbiota profile in healthy Indonesians.
    Rahayu ES; Utami T; Mariyatun M; Hasan PN; Kamil RZ; Setyawan RH; Pamungkaningtyas FH; Harahap IA; Wiryohanjoyo DV; Pramesi PC; Cahyanto MN; Sujaya IN; Juffrie M
    World J Gastroenterol; 2019 Mar; 25(12):1478-1491. PubMed ID: 30948911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High Heterogeneity of Multidrug-Resistant
    Djukovic A; González-Barberá EM; Sanz J; Artacho A; Peñaranda I; Herrera B; Garzón MJ; Salavert M; López-Hontangas JL; Xavier KB; Kuster B; Debrauwer L; Rolain JM; Sanz MA; Xavier JB; Ubeda C
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31767720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acquisition and colonization dynamics of antimicrobial-resistant bacteria during international travel: a prospective cohort study.
    Schaumburg F; Sertic SM; Correa-Martinez C; Mellmann A; Köck R; Becker K
    Clin Microbiol Infect; 2019 Oct; 25(10):1287.e1-1287.e7. PubMed ID: 30898722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobials increase travelers' risk of colonization by extended-spectrum betalactamase-producing Enterobacteriaceae.
    Kantele A; Lääveri T; Mero S; Vilkman K; Pakkanen SH; Ollgren J; Antikainen J; Kirveskari J
    Clin Infect Dis; 2015 Mar; 60(6):837-46. PubMed ID: 25613287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolonged carriage and potential onward transmission of carbapenemase-producing Enterobacteriaceae in Dutch travelers.
    van Hattem JM; Arcilla MS; Bootsma MC; van Genderen PJ; Goorhuis A; Grobusch MP; Molhoek N; Oude Lashof AM; Schultsz C; Stobberingh EE; Verbrugh HA; de Jong MD; Melles DC; Penders J
    Future Microbiol; 2016 Jul; 11():857-64. PubMed ID: 27357522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colonisation with multi-resistant Enterobacteriaceae in hospitalised Danish patients with a history of recent travel: a cross-sectional study.
    Lausch KR; Fuursted K; Larsen CS; Storgaard M
    Travel Med Infect Dis; 2013; 11(5):320-3. PubMed ID: 23810306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of short- and long-course antibiotics on the lower intestinal microbiome as they relate to traveller's diarrhea.
    McDonald LC
    J Travel Med; 2017 Apr; 24(suppl_1):S35-S38. PubMed ID: 28520993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gut microbiota composition in travellers is associated with faecal lipocalin-2, a mediator of gut inflammation.
    Gandasegui J; Vergara A; Fleitas P; Rubio E; Fernandez-Pittol M; Aylagas C; Alvarez M; Zancada N; Camprubí-Ferrer D; Vila J; Muñoz J; Petrone P; Casals-Pascual C
    Front Cell Infect Microbiol; 2024; 14():1387126. PubMed ID: 38736752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multi drug resistance and Extended Spectrum Beta Lactamases in clinical isolates of Shigella: A study from New Delhi, India.
    Aggarwal P; Uppal B; Ghosh R; Krishna Prakash S; Chakravarti A; Jha AK; Rajeshwari K
    Travel Med Infect Dis; 2016; 14(4):407-13. PubMed ID: 27233679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Composition of the intestinal microbiota in extended-spectrum β-lactamase-producing Enterobacteriaceae carriers and non-carriers in Thailand.
    Piewngam P; Quiñones M; Thirakittiwatthana W; Yungyuen T; Otto M; Kiratisin P
    Int J Antimicrob Agents; 2019 Apr; 53(4):435-441. PubMed ID: 30578963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microbial Community of Healthy Thai Vegetarians and Non-Vegetarians, Their Core Gut Microbiota, and Pathogen Risk.
    Ruengsomwong S; La-Ongkham O; Jiang J; Wannissorn B; Nakayama J; Nitisinprasert S
    J Microbiol Biotechnol; 2016 Oct; 26(10):1723-1735. PubMed ID: 27381339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of the human gut microbiome during travelers' diarrhea.
    Youmans BP; Ajami NJ; Jiang ZD; Campbell F; Wadsworth WD; Petrosino JF; DuPont HL; Highlander SK
    Gut Microbes; 2015; 6(2):110-9. PubMed ID: 25695334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A quantitative polymerase chain reaction assay for rapid detection of 9 pathogens directly from stools of travelers with diarrhea.
    Antikainen J; Kantele A; Pakkanen SH; Lääveri T; Riutta J; Vaara M; Kirveskari J
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1300-1307.e3. PubMed ID: 23639597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diversity and enterotype in gut bacterial community of adults in Taiwan.
    Liang C; Tseng HC; Chen HM; Wang WC; Chiu CM; Chang JY; Lu KY; Weng SL; Chang TH; Chang CH; Weng CT; Wang HM; Huang HD
    BMC Genomics; 2017 Jan; 18(Suppl 1):932. PubMed ID: 28198673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative gut microbiota and resistome profiling of intensive care patients receiving selective digestive tract decontamination and healthy subjects.
    Buelow E; Bello González TDJ; Fuentes S; de Steenhuijsen Piters WAA; Lahti L; Bayjanov JR; Majoor EAM; Braat JC; van Mourik MSM; Oostdijk EAN; Willems RJL; Bonten MJM; van Passel MWJ; Smidt H; van Schaik W
    Microbiome; 2017 Aug; 5(1):88. PubMed ID: 28803549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fecal Microbiota Signatures Are Associated with Response to Ustekinumab Therapy among Crohn's Disease Patients.
    Doherty MK; Ding T; Koumpouras C; Telesco SE; Monast C; Das A; Brodmerkel C; Schloss PD
    mBio; 2018 Mar; 9(2):. PubMed ID: 29535202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gut mucosal-associated microbiota better discloses inflammatory bowel disease differential patterns than faecal microbiota.
    Altomare A; Putignani L; Del Chierico F; Cocca S; Angeletti S; Ciccozzi M; Tripiciano C; Dalla Piccola B; Cicala M; Guarino MPL
    Dig Liver Dis; 2019 May; 51(5):648-656. PubMed ID: 30573380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.